Emgality (galcanezumab)
Migraine
ApprovedCommercial
Key Facts
About Eli Lilly
Eli Lilly is one of the world's largest pharmaceutical companies with over 145 years of experience in developing life-changing medicines. The company has achieved significant recent success with GLP-1 receptor agonists for diabetes and weight management, generating substantial revenue growth. Lilly continues to invest heavily in R&D across key therapeutic areas including diabetes, oncology, autoimmune diseases, and neurodegeneration, with a robust pipeline of innovative treatments in development.
View full company profileTherapeutic Areas
Other Migraine Drugs
| Drug | Company | Phase |
|---|---|---|
| Symbravo | Axsome Therapeutics | Approved |
| EVO756 | Evommune | Phase 1 |